Assignee
SAMUMED LLC
US·110 granted patents·7 pending applications·2,127 citations·filing 2013–2020
Top patents by PatentIndex Score
117 records- 0199US9844536B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Dec 19, 2017·49 cites·37 claims
- 0299US9828372B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 28, 2017·49 cites·36 claims
- 0399US9763951B23-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·36 claims
- 0499US9763927B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·26 claims
- 0599US9586977B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Mar 7, 2017·49 cites·22 claims
- 0699US9381192B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jul 5, 2016·49 cites·47 claims
- 0799US9233104B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 12, 2016·67 cites·28 claims
- 0899US9199991B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Dec 1, 2015·70 cites·38 claims
- 0999US8987298B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 24, 2015·77 cites·79 claims
- 1099US8901150B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Dec 2, 2014·77 cites·30 claims
- 1199US8703794B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Apr 22, 2014·81 cites·20 claims
- 1299US8697887B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2013·Granted Apr 15, 2014·104 cites·23 claims
- 1399US8673936B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 18, 2014·85 cites·28 claims
- 1499US8664241B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 4, 2014·83 cites·30 claims
- 1599US8618128B11H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 31, 2013·84 cites·30 claims
- 1699US8604052B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 10, 2013·92 cites·18 claims
- 1798US10407425B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2018·Granted Sep 10, 2019·15 cites·18 claims
- 1898US9889140B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Feb 13, 2018·23 cites·36 claims
- 1998US9855272B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Jan 2, 2018·44 cites·17 claims
- 2098US9815854B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 14, 2017·49 cites·37 claims
- 2198US9802916B2Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2015·Granted Oct 31, 2017·52 cites·3 claims
- 2298US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
- 2398US9540398B23-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 10, 2017·33 cites·32 claims
- 2498US9090613B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jul 28, 2015·84 cites·23 claims
- 2598US9067939B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jun 30, 2015·75 cites·18 claims
- 2698US9012472B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Apr 21, 2015·73 cites·77 claims
- 2798US8883822B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Nov 11, 2014·76 cites·16 claims
- 2898US8846714B21H-pyrazolo[3,4-β]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Sep 30, 2014·82 cites·32 claims
- 2997US10981909B2Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamideSAMUMED LLC·Filed 2020·Granted Apr 20, 2021·8 cites·22 claims
- 3097US10947228B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·9 cites·36 claims
- 3197US10131677B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2017·Granted Nov 20, 2018·15 cites·32 claims
- 3296US9994563B2Indazole inhibitors of the wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jun 12, 2018·7 cites·5 claims
- 3396US9795550B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2015·Granted Oct 24, 2017·12 cites·38 claims
- 3495US9951048B1Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Apr 24, 2018·13 cites·30 claims
- 3595US8629176B1β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Jan 14, 2014·17 cites·14 claims
- 3694US10434052B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2017·Granted Oct 8, 2019·3 cites·18 claims
- 3794US10287267B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted May 14, 2019·7 cites·30 claims
- 3894US9908867B23-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 6, 2018·20 cites·8 claims
- 3994US8921413B2β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Dec 30, 2014·14 cites·15 claims
- 4094US8815897B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Aug 26, 2014·82 cites·65 claims
- 4193US10947217B2Isoquinolin-3-YL carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·4 cites·40 claims
- 4293US9884053B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2016·Granted Feb 6, 2018·7 cites·42 claims
- 4393US9303010B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Apr 5, 2016·12 cites·11 claims
- 4491US9738638B22-(1H-indazol-3-yl)-3H-imidazo[4,5-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Aug 22, 2017·4 cites·31 claims
- 4591US9493437B2β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 4691US9493487B23-(1H-imidazo[4,5-C]pyridin-2-YL)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Nov 15, 2016·4 cites·31 claims
- 4791US9475807B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Oct 25, 2016·5 cites·32 claims
- 4890US10899757B22-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereofSAMUMED LLC·Filed 2016·Granted Jan 26, 2021·8 cites·8 claims
- 4990US10464924B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2017·Granted Nov 5, 2019·5 cites·37 claims
- 5090US9533976B2γ-diketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Jan 3, 2017·9 cites·3 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →